The Translation of New Therapy Interest Group aims to uniquely align researchers from academia, industry, and regulatory groups to leverage advanced molecular imaging to drive therapeutic discovery. Combining the principles of diagnostics and therapy, the Interest Group fosters collaboration and exchange of knowledge and proposes innovative research in the pursuit of improved therapeutic options for patients. The Interest Group will address the challenges that occur at the interface of discovery, translation, and clinical approval of therapy.

Members of TNT are directly engaged in emerging, multi-disciplinary topics, such as theranostics, image-guided interventions, companion diagnostics, and co-clinical trials. Unique to the WMIS, the TNT Interest Group devotes particular attention to chaperoning early discoveries towards clinical maturation, which by necessity will involve broad stakeholder engagement across the entire compendium of the therapeutics discovery process.

WMIS invites you to find your place to grow, collaborate and make a difference – join the TNT Interest Group today.

Members: Interest Groups are open to current WMIS Members. There is an annual Interest Group membership fee of $20 which is requested to help offset administrative costs. To join an interest group, please click the button below.

If you are not a current WMIS member, please click the button below and create a new profile to join WMIS and join interest groups.

Mission Statement

To accelerate the translation of cutting-edge molecular imaging technologies into practical applications for personalized medicine, targeted therapies, and disease management.